Nisa Investment Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.24M Sell
16,547
-1,750
-10% -$340K 0.01% 485
2025
Q4
$3.18M Buy
18,297
+247
+1% +$45K 0.01% 510
2025
Q3
$3.44M Buy
18,050
+6,892
+62% +$1.22M 0.01% 500
2025
Q2
$2M Buy
11,158
+321
+3% +$55.8K 0.01% 634
2025
Q1
$1.83M Buy
10,837
+282
+3% +$46.3K 0.01% 666
2024
Q4
$1.59M Buy
10,555
+402
+4% +$62.5K 0.01% 751
2024
Q3
$1.58M Buy
10,153
+48
+0.5% +$7.17K 0.01% 740
2024
Q2
$1.38M Sell
10,105
-1,169
-10% -$160K 0.01% 797
2024
Q1
$1.5M Buy
11,274
+399
+4% +$51.8K 0.01% 755
2023
Q4
$1.5M Sell
10,875
-1,949
-15% -$256K 0.01% 737
2023
Q3
$1.56M Sell
12,824
-9,201
-42% -$1.23M 0.01% 738
2023
Q2
$3.1M Buy
22,025
+691
+3% +$95.3K 0.02% 549
2023
Q1
$3.02M Sell
21,334
-3,146
-13% -$450K 0.02% 546
2022
Q4
$3.83M Sell
24,480
-1,391
-5% -$200K 0.03% 523
2022
Q3
$3.2M Sell
25,871
-4,284
-14% -$564K 0.03% 503
2022
Q2
$4.01M Buy
30,155
+14,739
+96% +$2.01M 0.04% 437
2022
Q1
$2.11M Sell
15,416
-4,548
-23% -$634K 0.01% 655
2021
Q4
$2.7M Sell
19,964
-7,028
-26% -$1.07M 0.02% 561
2021
Q3
$3.92K Sell
26,992
-2,735
-9% -$400K 0.02% 511
2021
Q2
$3.92K Sell
29,727
-8,050
-21% -$1.05M 0.02% 528
2021
Q1
$4.85K Sell
37,777
-100
-0.3% -$12.3K 0.03% 453
2020
Q4
$4.51M Buy
37,877
+1,555
+4% +$190K 0.03% 478
2020
Q3
$4.16M Sell
36,322
-13,745
-27% -$1.62M 0.03% 415
2020
Q2
$5.71M Sell
50,067
-1,563
-3% -$166K 0.05% 311
2020
Q1
$4.15M Buy
51,630
+11,350
+28% +$1.18M 0.05% 347
2019
Q4
$4.3M Sell
40,280
-11,637
-22% -$1.21M 0.04% 416
2019
Q3
$5.56M Buy
51,917
+15,488
+43% +$1.59M 0.05% 355
2019
Q2
$3.71M Sell
36,429
-10,830
-23% -$1.04M 0.04% 442
2019
Q1
$4.25M Buy
47,259
+3,878
+9% +$336K 0.04% 397
2018
Q4
$3.61M Sell
43,381
-650
-1% -$60.9K 0.04% 399
2018
Q3
$4.75M Buy
44,031
+6,444
+17% +$707K 0.04% 387
2018
Q2
$4.13M Buy
37,587
+500
+1% +$52.1K 0.04% 403
2018
Q1
$3.75M Sell
37,087
-4,500
-11% -$461K 0.04% 421
2017
Q4
$4.1M Sell
41,587
-2,100
-5% -$199K 0.04% 386
2017
Q3
$4.09M Buy
43,687
+12,000
+38% +$1.27M 0.05% 383
2017
Q2
$3.5M Hold
31,687
0.04% 416
2017
Q1
$3.11M Buy
31,687
+2,695
+9% +$257K 0.04% 460
2016
Q4
$2.66M Buy
28,992
+3,125
+12% +$269K 0.03% 503
2016
Q3
$2.19M Sell
25,867
-4,500
-15% -$378K 0.03% 549
2016
Q2
$2.47M Buy
30,367
+3,200
+12% +$244K 0.03% 490
2016
Q1
$1.94M Hold
27,167
0.03% 552
2015
Q4
$1.93M Sell
27,167
-11,200
-29% -$753K 0.03% 549
2015
Q3
$2.37M Buy
38,367
+5,000
+15% +$349K 0.04% 479
2015
Q2
$2.42M Buy
33,367
+4,900
+17% +$362K 0.03% 490
2015
Q1
$2.19M Sell
28,467
-1,000
-3% -$71.6K 0.03% 550
2014
Q4
$1.98M Buy
29,467
+8,500
+41% +$536K 0.03% 588
2014
Q3
$1.27M Buy
20,967
+5,000
+31% +$308K 0.02% 690
2014
Q2
$937K Buy
15,967
+1,700
+12% +$99.6K 0.01% 830
2014
Q1
$826K Buy
14,267
+2,000
+16% +$107K 0.01% 869
2013
Q4
$657K Sell
12,267
-900
-7% -$53.4K 0.01% 942
2013
Q3
$814K Sell
13,167
-19,000
-59% -$1.14M 0.01% 849
2013
Q2
$1.95M Buy
+32,167
New +$1.92M 0.03% 525

Other funds holding DGX

Nisa Investment Advisors's DGX Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Quest Diagnostics (DGX) stake by 9.6% in Q1 2026, selling an estimated $340K and leaving 16,547 shares worth $3.24M. The position accounts for 0.01% of the portfolio, ranked #485.

Nisa Investment Advisors first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.71M in Q2 2020. 1,066 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Nisa Investment Advisors held 16,547 shares of Quest Diagnostics worth $3.24M as of Q1 2026.
  • Nisa Investment Advisors sold 1,750 Quest Diagnostics shares in Q1 2026, an estimated $340K.
  • Quest Diagnostics made up 0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #485 holding.
  • Nisa Investment Advisors first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Nisa Investment Advisors's Quest Diagnostics position peaked at $5.71M in Q2 2020.
  • 1,066 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.